SEC Form 4 · accession 0001179110-16-021465
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G. Rao Srinivas
Officer — SVP and Chief Medical Officer
Period of report
Mar 8, 2016
Accepted (ET)
Mar 9, 2016 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 8, 2016 | M | 2,535 | $11.83 | A | 6,909 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $11.83 | Mar 8, 2016 | M | 2,535 | D | — | Jul 16, 2024 | Common Stock | 2,535 | 147,465 | D |
Explanation of responses
- F1150,000 stock options were granted on July 16th, 2014 and were exercisable on July 16th, 2015 with respect to 25% of the underlying shares and in equal monthly installments for the 36 months thereafter. The stock options exercised on March 8, 2016 were Incentive Stock Options (ISOs).